Anti-SARS-CoV-2 IgY Isolated from Egg Yolks of Hens Immunized with Inactivated SARS-CoV-2 for Immunoprophylaxis of COVID-19  

作　　者：Haiyan Shen Yanxing Cai Huan Zhang Jie Wu Lin Ye Penghui Yang Xiaojun Lin Shibo Jiang Ming Liao 

机构地区：[1]Institute of Animal Health,Guangdong Academy of Agricultural Sciences,Guangzhou 510640,China [2]Key Laboratory of Medical Molecular Virology(MOE/NHC/CAMS),School of Basic Medical Sciences,Fudan University,Shanghai 200032,China [3]Guangdong Provincial Center for Disease Control and Prevention,Guangzhou 511430,China [4]Chengdu YuKang Biotechnology Co.,LTD,Chengdu 611633,China [5]Fifth Medical Center of Chinese,PLA General Hospital,Beijing 100039,China

出　　处：《Virologica Sinica》2021年第5期1080-1082,共3页中国病毒学（英文版）

基　　金：supported by grants from the Key Research and Development Project of Guangdong Province(202020012624900001);the National Natural Science Foundation of China(31830097,31802174 and 82041025);the Key Research and Development Project of Guangdong Province(2020B1111320001);the Special fund for the Scientific innovation strategy-construction ofhigh level Academyof Agriculture Science-Prominent Talents(R2020PY-JC001)。

摘　　要：Dear Editor,In the absence of vaccine,the mounting second wave of COVID-19 infections worldwide calls for the rapid development of human neutralizing antibodies to prevent and treat COVID-19(Lee et al.2020).Considering the high cost and long development cycle of human neutralizing antibodies,we turned to anti-SARS-Co V-2 Ig Y for cheap and fast scale up.

关 键 词：MOUNT neutral COV 

分 类 号：R392-33[医药卫生—免疫学]